Althian - Clinical Research Management Center

Advanced BioScience Laboratories, Inc (ABL) is a leading contract research and manufacturing organization, that partners with our clients to support their vaccine and therapeutic development programs. We offer a unique combination of preclinical and clinical services designed to first address the scientific challenges often encountered during proof-of-concept, and then streamline process development and cGMP production of clinical supply.
ABL can assist with all aspects of production development including, but not limited to:
Basic and translational research
Vaccine and therapeutic product design
Animal models for preclinical evaluation including immunomonitoring , efficacy and potency
Cell line and process development
cGMP manufacture of cell banks and virus banks
cGMP manufacture of clinical supply for protein therapeutics, vaccines and live viral vectors

Ask about our 9,000 sq ft clinical GCLP immunomonitoring space and our vaccine and therapeutic testing services.

With a 50+ year history as a service provider to the life sciences industry, ABL brings a broad technical knowledge base, highly experienced work force, and seasoned project management to every program. Our goal is to become a seamless extension of our clients’ product development group – helping them advance today’s ideas into tomorrow’s medicines. Our history, capabilities and expertise allow ABL to provide solution based services to our clients.

Absorption Systems, a Pharmaron company, is a full-service nonclinical CRO developing innovative services and solutions for the pharmaceutical, biotech, medical device and regenerative medicine industry. Our services include research and testing for small molecules, large molecules, biologics, medical device and cell and gene therapy products. The company's mission is to continually develop innovative research tools that can be used to accurately predict human outcomes or to explain unanticipated outcomes when they occur. The company's facilities are strategically located in Philadelphia, San Diego, and Boston, servicing hundreds of customers throughout the world. Our focus is to maintain accuracy, timelines, and reliability at every stage of development. For more information on the company's comprehensive contract services and applied research programs, please visit absorption.com.

Accel Research Sites is a multi-therapeutic network of clinical research sites dedicated to the expert delivery of treatment options to patients and providers. We partner with the most innovative and significant pharmaceutical, biotechnology, and medical device companies in the world to advance healthcare and wellness in the communities we serve.

Accelerated Enrollment Solutions (AES) helps biopharmaceutical companies overcome patient recruitment and research site challenges to deliver greater speed, certainty, and control to clinical trial delivery.

Through the combination of a powerful patient recruiting solution and more than 160 owned and partnered clinical research sites throughout the world, AES provides a single global source for clinical trial sites and patients that delivers centralized control, consistent operations and quality worldwide, and more patients from fewer sites in less time.

AES is a business of PPD, a leading global contract research organization providing comprehensive, integrated drug development, laboratory and lifecycle management services.

For more information, visit www.globalAES.com.

Our vision is to conduct clinical trials better and more cost effectively than anyone else. We accomplish this by working with our clients to not only deliver the clinical trial effectively, on time and within budget, but also by leveraging our in-depth expertise to ensure the clinical trial is properly designed.

We believe there is increasing need for innovation, creativity and scientific expertise in clinical research, characteristics often synonymous with small Biopharma and hence, though we are proud to have a number of the world’s largest pharmaceutical companies as our clients, greater than 80% of our client portfolio is small Biopharma.

ACLIRES has performed trials for an international array of biotech companies as well as for some of the largest global pharmaceutical companies. With our broad access to patients and expertise, our aim is to rapidly initiate our client’s studies, even when a very special patient population is required.

Our services include:
- Early Phase Studies
- Late Phase Studies
- Recruitment
- Regulatory Affairs
- Monitoring
- Site Selection
- Scientific Services/Medical Writing
- Consulting
- Quality Management